Crosstalk between exosomes and tumor-associated macrophages in hepatocellular carcinoma: implication for cancer progression and therapy
Authors:
Open Access
- 8 April 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1512480
Abstract
Hepatocellular carcinoma (HCC), the most prevalent type of primary liver cancer, represents a significant cause of cancer-related mortality. While our understanding of its pathogenesis is comparatively comprehensive, the influence of the tumor microenvironment (TME) on its progression warrants additional investigation. Tumor-associated macrophages (TAMs) have significant impacts on cancer cell proliferation, migration, invasion, and immune response, facilitating a complex interaction within the TME. Exosomes, which measure between 30 and 150 nanometers in size, are categorized into small extracellular vesicles, secreted by a wide range of eukaryotic cells. They can transfer biological molecules including proteins, non-coding RNAs, and lipids, which mediates the intercellular communication within the TME. Emerging evidence has revealed that exosomes regulate macrophage polarization, thus impacting cancer progression and immune responses within the TME of HCC. Moreover, TAM-derived exosomes also play crucial roles in malignant transformation, which hold immense potential for cancer therapy. In this review, we elaborate on the crosstalk between exosomes and TAMs within TME during HCC development. Moreover, we delve into the feasible treatment approaches for exosomes in cancer therapy and emphasize the limitations and challenges for the translation of exosomes derived from TAMs into clinical courses for cancer therapy, which may provide new perspectives on further ameliorations of therapeutic regimes based on exosomes to advance their clinical applications.Keywords
This publication has 165 references indexed in Scilit:
- Lenvatinib‐resistant hepatocellular carcinoma promotes malignant potential of tumor‐associated macrophages via exosomal miR‐301a‐3pAnnals of Gastroenterological Surgery, 2024
- Management of Hepatocellular CarcinomaJAMA Surgery, 2023
- ALKBH5‐mediated m6A demethylation of TIRAP mRNA promotes radiation‐induced liver fibrosis and decreases radiosensitivity of hepatocellular carcinomaClinical and Translational Medicine, 2023
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapyCancer Communications, 2022
- Exosome Processing and Characterization Approaches for Research and Technology DevelopmentAdvanced Science, 2022
- Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of GlioblastomaAdvanced Materials, 2022
- HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarizationCancer Medicine, 2021
- SENP3 loss promotes M2 macrophage polarization and breast cancer progressionMolecular Oncology, 2021
- Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR‐23a‐3p and Up‐regulate Programmed Death Ligand 1 Expression in MacrophagesHepatology, 2019
- Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinomaHepatology, 2017